首页|复方喜树颗粒调控铁死亡抑制肝细胞癌增殖的作用机制

复方喜树颗粒调控铁死亡抑制肝细胞癌增殖的作用机制

扫码查看
目的:探讨复方喜树颗粒调控铁死亡途径抑制肝细胞癌增殖的作用机制。方法:建立人肝癌Huh7裸鼠移植瘤模型,随机分为模型组,复方斑蝥组(0。21 g·kg-1),复方喜树颗粒低(1。87g·kg-1)、中(3。74g·kg-1)、高剂量组(7。49 g·kg-1),模型组予以饮用水,各给药组给予相应药物,连续灌胃28 d,每4 d测量裸鼠体质量和肿瘤体积,苏木素-伊红(HE)染色观察肿瘤组织病理学变化。细胞实验采用细胞增殖与活性检测(CCK-8)法检测24、48 h复方喜树颗粒(0、31。25、62。5、125、250、500、1 000 mg·L-1)对人肝癌Huh7细胞增殖能力的影响;采用铁离子荧光探针(CA-AM)、活性氧荧光探针(DCFH-DA)和脂质过氧化物荧光探针(C11-BODIPY581/591)分别检测细胞内二价铁离子(Fe2+)、活性氧(ROS)和细胞内脂质过氧化物(LPO)水平;比色法检测细胞内谷胱甘肽(GSH)和超氧化物歧化酶(SOD)水平;蛋白免疫印迹法(Western blot)检测谷胱甘肽过氧化物酶4(GPX4),转铁蛋白受体1(TFR1)、铁蛋白重链1(FTH1)的蛋白表达情况。结果:在裸鼠移植瘤实验中,给药期间,与模型组比较,第12天开始,各给药组的移植瘤体积明显减小(P<0。05,P<0。01),给药结束后,与模型组比较,复方斑蝥组和复方喜树颗粒低、中、高剂量组移植瘤体积、相对肿瘤体积、移植瘤重量明显减小(P<0。05),抑瘤率分别为48。99%、79。93%、91。38%、97。36%,且与复方斑蝥组比较,复方喜树颗粒低、中、高剂量组移植瘤体积,相对肿瘤体积均明显减小(P<0。05),中、高剂量组移植瘤重量明显减小(P<0。05);HE染色发现,与模型组比较,各给药组癌细胞数量减少,可见坏死病灶,出现细胞核固缩、核碎裂、核溶解,高剂量组可见间质纤维细胞比例增加。细胞水平上,与空白组比较,复方喜树颗粒组孵育24、48 h后可明显降低Huh7细胞存活率,呈剂量依赖性(P<0。05);与空白组比较,RSL3组和复方喜树颗粒低、中、高剂量组CA-AM相对荧光强度显著下降,说明Fe2+含量显著上升(P<0。01);与空白组比较,RSL3组和复方喜树颗粒低、中、高剂量组的DCFH-DA的荧光强度明显升高,说明ROS含量明显上升(P<0。05);与空白组比较,RSL3组和复方喜树颗粒低、中、高剂量组的C11-BODIPY581/591荧光比值显著升高,说明LPO水平显著升高(P<0。01)。与空白组比较,RSL3组和复方喜树颗粒低、中、高剂量组内GSH、SOD水平明显下降(P<0。05);与空白组比较,RSL3组和复方喜树颗粒中、高剂量组GPX4、FTH1蛋白表达明显下降(P<0。05);与空白组比较,复方喜树颗粒低、高剂量TFR1蛋白表达明显上升(P<0。05)。结论:复方喜树颗粒可能通过下调GSH-GPX4信号轴使抗氧化系统失衡,提高细胞内Fe2+和脂质过氧化物水平,诱导肝癌细胞铁死亡,从而发挥抗肝细胞癌增殖的作用。
Compound Xishu Granules Inhibit Proliferation of Hepatocellular Carcinoma Cells by Regulating Ferroptosis
Objective:To study the mechanism of compound Xishu granules(CXG)in inhibiting the proliferation of hepatocellular carcinoma cells by regulating ferroptosis.Methods:The transplanted tumor model of human Huh7 was established with nude mice and the successfully modeled mice were randomized into model,Fufang Banmao(0.21 g·kg-1),low-dose(1.87 g·kg-1)CXG,medium-dose(3.74 g·kg-1)CXG,and high-dose(7.49 g·kg-1)CXG groups.Mice were administrated with drinking water or CXG for 28 days,and the body weight and tumor volume were measured every 4 days.Hematoxylin-eosin staining was employed to observe the histopathological changes of tumors.The cell-counting kit-8(CCK-8)was used to examine the survival rate of Huh7 cells treated with different concentrations(0,31.25,62.5,125,250,500,1 000 mg·L-1)of CXG for 24 h and 48 h.CA-AM,DCFH-DA,and C11-BODIPY581/591 fluorescent probes were used to determine the intracellular levels of ferrous ion(Fe2+),reactive oxygen species(ROS),and lipid peroxide(LPO),respectively.The colorimetric method was employed to measure the levels of glutathione(GSH)and superoxide dismutase(SOD).Western blot was employed to determine the protein levels of glutathione peroxidase 4(GPX4),transferrin receptor 1(TFR1),and ferritin heavy chain 1(FTH1),respectively.Results:In the animal experiment,compared with the model group,the drug treatment groups showed reductions in the tumor volume from day 12(P<0.01).After treatment,the Fufang Banmao and low-,medium-,and high-dose CXG groups had lower tumor volume,relative tumor volume,and tumor weight than the model group(P<0.05),with tumor inhibition rates of 48.99%,79.93%,91.38%,and 97.36%,respectively.Moreover,the CXG groups had lower tumor volume and relative tumor volume(P<0.05 in all the three dose groups)and lower tumor weight(P<0.05 in medium-dose and high-dose groups)than the Fufang Banmao group.Compared with the model group,the drug treatment groups showed reduced number of tumor cells,necrotic foci with karyopyknosis,nuclear fragmentation,and nucleolysis,and the high-dose CXG group showed an increase in the proportion of interstitial fibroblasts.In the cell experiment,compared with the blank group,CXG reduced the survival rate of Huh7 cells in a dose-dependent manner after incubation for 24 h and 48 h(P<0.05).Compared with the blank group,the RSL3 group and the low-,medium-,and high-dose CXG groups showed a decrease in the relative fluorescence intensity of CA-AM and increases in the fluorescence intensity of DCFH-DA and fluorescence ratio of C11-BODIPY581/591,which indicated elevations in the levels of Fe2+(P<0.01),ROS(P<0.05),and LPO(P<0.01),respectively.Compared with the blank group,the RSL3 and low-,medium-,and high-dose CXG groups showed lowered levels of GSH and SOD(P<0.05).In addition,the RSL3 group and the medium-and high-dose CXG groups showed down-regulated expression of GPX4 and FTH1(P<0.05),and the low-and high-dose CXG groups presented up-regulated expression of TFR1(P<0.05).Conclusion:CXG suppresses the proliferation of hepatocellular carcinoma cells by inducing ferroptosis via downregulating the GSH-GPX4 signaling axis and increasing intracellular Fe2+and LPO levels.

compound Xishu granuleshepatocellular carcinomaferroptosisproliferationtraditional Chinese medicine

田源、王宇僖、刘震、马筠程、朱泓宇、王筱竺、李倩、高健、王伟玲、徐文慧、王停

展开 >

北京中医药大学中药学院,北京 100029

北京中医药大学生命科学学院,北京 100029

北京中医药大学北京中医药研究院,北京 100029

复方喜树颗粒 肝细胞癌 铁死亡 增殖 中药

2025

中国实验方剂学杂志
中国中医科学院中药研究所 中国中西医结合学会中药专业委员会

中国实验方剂学杂志

北大核心
影响因子:1.62
ISSN:1005-9903
年,卷(期):2025.31(2)